Bristol-Myers Squibb's Opdivo Qvantig Gets US FDA Approval
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
56.85 USD | -0.99% |
|
-3.56% | +0.51% |
Feb. 07 | Leerink Partners Adjusts Price Target on Bristol-Myers Squibb to $68 From $73 | MT |
Feb. 07 | Wells Fargo Adjusts Price Target on Bristol-Myers Squibb to $62 From $60 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration